Eotaxin/CCL11, human recombinant protein
human Eotaxin
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P51671 |
|---|---|
| Calculated MW | 8.3 kDa |
| Gene ID | 6356 |
|---|---|
| Gene Symbol | CCL-11 |
| Other Names | Eotaxin, C-C motif chemokine 11, Eosinophil chemotactic protein, Small-inducible cytokine A11 |
| Gene Source | Human |
| Source | E. coli |
| Assay&Purity | SDS-PAGE; ≥97% |
| Assay2&Purity2 | HPLC; ≥97% |
| Recombinant | Yes |
| Results | 10 ng/ ml |
| Target/Specificity | Eotaxin |
| Application Notes | The lyophilized Eotaxin can be reconstituted in water to a concentration of 0.1-1 µg/ µl. It is recommended that further dilutions be made into buffer containing carrier protein or medium containing serum. |
| Format | Lyophilized protein |
| Storage | -20°C; Lyophilized from 20 mM phosphate buffer (pH 7.4) and 150 mM NaCl. |

Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Eotaxin is a recently discovered chemokine characterized by its high chemotactic selectivity for eosinophils. The position of the four cystein residues in Eotaxin places it in the C-C family of chemokines, along with chemokines such as RANTES, MCP-3, and MIP-1 alpha. The human Eotaxin is an 8.3 kDa protein containing 74 amino acid residues. The sequence of the first five N-terminal amino acids is Gly-Pro-Ala-Ser-Val.
References
Garcia-Zepeda E.A.,et al.Nat. Med. 2:449-456(1996).
Ponath P.D.,et al.J. Clin. Invest. 97:604-612(1996).
Kitaura M.,et al.J. Biol. Chem. 271:7725-7730(1996).
Bartels J.,et al.Biochem. Biophys. Res. Commun. 225:1045-1051(1996).
Garcia-Zepeda E.A.,et al.Genomics 41:471-476(1997).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.





Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.

